Compare EWTX & SON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EWTX | SON |
|---|---|---|
| Founded | 2017 | 1899 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Containers/Packaging |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.9B |
| IPO Year | 2021 | 2014 |
| Metric | EWTX | SON |
|---|---|---|
| Price | $38.15 | $49.83 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 11 |
| Target Price | $52.62 | ★ $59.33 |
| AVG Volume (30 Days) | ★ 1.4M | 897.5K |
| Earning Date | 11-05-2026 | 10-21-2026 |
| Dividend Yield | N/A | ★ 4.34% |
| EPS Growth | N/A | ★ 510.30 |
| EPS | N/A | ★ 0.68 |
| Revenue | N/A | ★ $7,518,753,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.04 |
| P/E Ratio | ★ N/A | $73.25 |
| Revenue Growth | N/A | ★ 41.72 |
| 52 Week Low | $14.68 | $38.65 |
| 52 Week High | $48.51 | $60.67 |
| Indicator | EWTX | SON |
|---|---|---|
| Relative Strength Index (RSI) | 41.39 | 50.57 |
| Support Level | $37.75 | $46.80 |
| Resistance Level | $41.22 | $50.90 |
| Average True Range (ATR) | 1.68 | 1.15 |
| MACD | -0.17 | 0.38 |
| Stochastic Oscillator | 39.04 | 74.45 |
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is developing novel therapeutics for muscular dystrophies and serious cardiac conditions. The company's product candidates are Sevasemten, EDG-7500, EDG-003, and EDG-15400. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies, including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company's products are currently in different stages of their development, being developed to target key muscle proteins and modulators to address a broad array of muscle diseases.
Sonoco Products Co is engaged in the manufacture and supply of consumer and industrial packaging products, offering paper, metal, and plastic packaging solutions across multiple end markets. The company has two reportable segments: Consumer Packaging and Industrial Paper Packaging. The Consumer Packaging segment provides rigid packaging solutions mainly for food, beverage, household, personal care, and pharmaceutical products, while the Industrial Paper Packaging segment produces paper-based packaging materials such as tubes, cores, and protective packaging, supported by paper mills and recycling operations, serving industrial and consumer markets. It generates the majority of its revenue from the Consumer Packaging segment.